Skip to main content

Matt McCall’s pitch on Cas9 treatment and testing platform

Does anyone know the leading company Matt McCall is pitching specific to CRISPR Cas9 genetic testing? Apparently this one entity has the IP where their technology must be licensed for others to use their testing platform.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.